In-Person Workshops

Designed for the real challenges of entering the US market from a European perspective with US expertise

Half day, full day, and multi-day workshops that get straight to business

Intense, straightforward workshops on where European value propositions get adopted fastest, how to read the systems, and how to win both home and abroad

Not generic advice

Learn what works in the real world: incentive, procurement, and economic alignment across European and US models so participants leave equipped to navigate multiple markets.

Directed at commercialization

Everything else is tablestakes; commercialization is how businesses get made. We get into the things that make or break the P&L.

Action over theory

Participants leave with action plans, decision points, and the knowledge to determine what’s real, what’s noise, and what’s next.

Tailored workshops for new market expansion

No two workshops are exactly alike, but we focus on providing an intense curriculum designed to teach participants how to “read” the systems at play so they can make stronger decisions themselves. We tailor to specific therapeutic areas, modalities, stages, and regions to make sure the information is extremely relevant. Advanced workshops may have prerequisites and are designed to leave participants with real-world tools to put to practice.

Half-day, full-day, and multi-day programs

Active group work with real-world case studies

Specific, practical tools and resources

Current to ongoing shifts and changes

Workshop concentrations

Transatlantic Commericalization

Business model fit and the foundation for a reality-based market strategy aimed at preserving optionality and accelerating market uptake and expansion.

Access to investment

Risk and strategic thinking

Alternate forms of investment

CLEAR/IT framework methodology

Translating EU-native strengths into the US model spectrum

Business model and market strategy for transatlantic scale

Procurement, pricing, and basic US health economics

Fundraising from US investors in 2026

Creating optionality in uncertain times

Reimbursement and working with payers

Designing the right sales structure

Investment narrative and runway alignment

Risk management in testing new markets

Due diligence and data rooms

Hedging bets in features and pricing

Pricing and value engineering to win value-based deals

Early revenue, partnerships, and distribution plays

Risk from an investment perspective

Designing governance for both US and EU

FAQs

  • Yes, and much more systematically and in-depth than many do because many of the typical reimbursement pathways don’t reflect the value propositions that European startups propose. The result is that they pursue reimbursement that still doesn’t lead to adoption.

    This is why it’s critical to work with those who understand multiple health models and true health economics.

  • No, although we do consider ourselves US experts. We also teach market access for the UK and Germany, and also teach courses on health economics and comparative health systems across the EU, ANZ, and US.

  • In-person will always be more engaging, particularly as we usually have the opportunity to train cluster leaders and BDMs while there. Depending on the length, we aim to incorporate small group work during the sessions, which is more difficult to do virtually.

    That said, our virtual workshops make a low-friction way to support a larger range of entrepreneurs.